Peptide record

TPDB09711

Antibacterial Antifungal Antiparasitic Hemolysis Toxicity standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09711
Antibacterial Antifungal Antiparasitic Hemolysis Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AFP-GFuse Antifungipept CAFPdb dbAMP 3.0 APD_complete PD_Hemolysis ToxinPred 3.0
standard
No
A 21-aa standard-residue multi-activity (Antibacterial, Antifungal, Antiparasitic, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GFLDIVKGVGKVALGAVSKLF
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C101H168N24O25
RNCEQHMPTWY
GV
2118.59
10.32
3
1
12
+2
-0.97
1.157
139.05
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
1
Residue Composition
number
2
A
0
R
0
N
1
D
0
C
0
E
0
Q
4
G
0
H
1
I
3
L
3
K
0
M
2
F
0
P
1
S
0
T
0
W
0
Y
4
V
Amino Acid Distribution
A: 2 R: 0 N: 0 D: 1 C: 0 E: 0 Q: 0 G: 4 H: 0 I: 1 L: 3 K: 3 M: 0 F: 2 P: 0 S: 1 T: 0 W: 0 Y: 0 V: 4
Chemical Descriptors
21 reviewed residue count
C101H168N24O25 sequence-only estimate (linear, free termini)
2118.59 sequence-only estimate (linear, free termini)
10.32 sequence-only estimate (linear, free termini)
+2 sequence-only estimate (linear, free termini)
-0.97 sequence-only estimate (linear, free termini)
1.157 sequence-only estimate (linear, free termini)
Evidence Records 17 records
Evidence 1 Activity

Activity

IC50
Antibacterial
2.87 µM

Target

T. cruzi Trypomastigotes

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
ctive against E. coli (15.1 uM), S. aureus (3.8 uM), and C. albicans (3.8 uM). Parasites: T. cruzi Trypomastigotes (IC50 2.87 uM) or Amastigotes (IC50 16.72 uM), P. falciparum NF54 (IC50 31.16 uM) or TM90C2B (IC50 16.76
Evidence 2 Activity

Activity

IC50
Antibacterial
31.16 µM

Target

P. falciparum NF54

Source & Reference

dbAMP DRAMP

Other

8 uM). Parasites: T. cruzi Trypomastigotes (IC50 2.87 uM) or Amastigotes (IC50 16.72 uM), P. falciparum NF54 (IC50 31.16 uM) or TM90C2B (IC50 16.76 uM), L. Mexicana (IC50 0.54 uM) ( Proaño-Bolaños et al., 2024 . Up
Evidence 3 Activity

Activity

IC50
Antibacterial
0.54 µM

Target

L. Mexicana

Source & Reference

dbAMP DRAMP

Other

astigotes (IC50 16.72 uM), P. falciparum NF54 (IC50 31.16 uM) or TM90C2B (IC50 16.76 uM), L. Mexicana (IC50 0.54 uM) ( Proaño-Bolaños et al., 2024 . Updated 7/2021 7/2024
Evidence 4 Activity

Activity

IC50
Antifungal
2.87 µM

Target

T. cruzi Trypomastigotes

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
ctive against E. coli (15.1 uM), S. aureus (3.8 uM), and C. albicans (3.8 uM). Parasites: T. cruzi Trypomastigotes (IC50 2.87 uM) or Amastigotes (IC50 16.72 uM), P. falciparum NF54 (IC50 31.16 uM) or TM90C2B (IC50 16.76
Evidence 5 Activity

Activity

IC50
Antifungal
31.16 µM

Target

P. falciparum NF54

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

8 uM). Parasites: T. cruzi Trypomastigotes (IC50 2.87 uM) or Amastigotes (IC50 16.72 uM), P. falciparum NF54 (IC50 31.16 uM) or TM90C2B (IC50 16.76 uM), L. Mexicana (IC50 0.54 uM) ( Proaño-Bolaños et al., 2024 . Up
Evidence 6 Activity

Activity

IC50
Antifungal
0.54 µM

Target

L. Mexicana

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

astigotes (IC50 16.72 uM), P. falciparum NF54 (IC50 31.16 uM) or TM90C2B (IC50 16.76 uM), L. Mexicana (IC50 0.54 uM) ( Proaño-Bolaños et al., 2024 . Updated 7/2021 7/2024
Evidence 7 Activity

Activity

IC50
Antiparasitic
2.87 µM

Target

T. cruzi Trypomastigotes

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets. dbAMP 3.0 classified under the Anti-parasitic function class.
ctive against E. coli (15.1 uM), S. aureus (3.8 uM), and C. albicans (3.8 uM). Parasites: T. cruzi Trypomastigotes (IC50 2.87 uM) or Amastigotes (IC50 16.72 uM), P. falciparum NF54 (IC50 31.16 uM) or TM90C2B (IC50 16.76
Evidence 8 Activity

Activity

IC50
Antiparasitic
31.16 µM

Target

P. falciparum NF54

Source & Reference

dbAMP 3.0 DRAMP

Other

8 uM). Parasites: T. cruzi Trypomastigotes (IC50 2.87 uM) or Amastigotes (IC50 16.72 uM), P. falciparum NF54 (IC50 31.16 uM) or TM90C2B (IC50 16.76 uM), L. Mexicana (IC50 0.54 uM) ( Proaño-Bolaños et al., 2024 . Up
Evidence 9 Activity

Activity

IC50
Antiparasitic
0.54 µM

Target

L. Mexicana

Source & Reference

dbAMP 3.0 DRAMP

Other

astigotes (IC50 16.72 uM), P. falciparum NF54 (IC50 31.16 uM) or TM90C2B (IC50 16.76 uM), L. Mexicana (IC50 0.54 uM) ( Proaño-Bolaños et al., 2024 . Updated 7/2021 7/2024
Evidence 10 Activity

Activity

9% Hemolysis
Toxicity
16 µg/mL
Hemolytic Cytotoxic
9% Hemolysis | 16 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Peptidomic approach identifies cruzioseptins, a new family of potent antimicrobial peptides in the splendid leaf frog, Cruziohyla calcarifer. | J Proteomics | 2016
Evidence 11 Activity

Activity

20% Hemolysis
Toxicity
32 µg/mL
Hemolytic Cytotoxic
20% Hemolysis | 32 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Peptidomic approach identifies cruzioseptins, a new family of potent antimicrobial peptides in the splendid leaf frog, Cruziohyla calcarifer. | J Proteomics | 2016
Evidence 12 Activity

Activity

33% Hemolysis
Toxicity
64 µg/mL
Hemolytic Cytotoxic
33% Hemolysis | 64 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Peptidomic approach identifies cruzioseptins, a new family of potent antimicrobial peptides in the splendid leaf frog, Cruziohyla calcarifer. | J Proteomics | 2016
Evidence 13 Activity

Activity

62% Hemolysis
Toxicity
128 µg/mL
Hemolytic Cytotoxic
62% Hemolysis | 128 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Peptidomic approach identifies cruzioseptins, a new family of potent antimicrobial peptides in the splendid leaf frog, Cruziohyla calcarifer. | J Proteomics | 2016
Evidence 14 Activity

Activity

100% Hemolysis
Toxicity
256 µg/mL
Hemolytic Cytotoxic
100% Hemolysis | 256 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Peptidomic approach identifies cruzioseptins, a new family of potent antimicrobial peptides in the splendid leaf frog, Cruziohyla calcarifer. | J Proteomics | 2016
Evidence 15 Activity

Activity

1% Hemolysis
Toxicity
8 µg/mL
Hemolytic Cytotoxic
1% Hemolysis | 8 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Peptidomic approach identifies cruzioseptins, a new family of potent antimicrobial peptides in the splendid leaf frog, Cruziohyla calcarifer. | J Proteomics | 2016
Evidence 16 Activity

Activity

50% Cytotoxicity
Toxicity
112.34±0.2 µM
Cytotoxic
50% Cytotoxicity | 112.34±0.2 | µM | target cell: Bone marrow-derived macrophages (BMDMs)

Target

Bone marrow-derived macrophages (BMDMs)

Source & Reference

NA
DBAASP
Cruzioseptins, antibacterial peptides from Cruziohyla calcarifer skin, as promising leishmanicidal agents. | Pathog Dis | 2020
Evidence 17 Hemolysis

Source & Reference

APD_complete PD_Hemolysis
APD_complete PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation.